View Financial HealthAcusensus 配当と自社株買い配当金 基準チェック /06Acusensus配当金を支払った記録がありません。主要情報n/a配当利回り-13.8%バイバック利回り総株主利回り-13.8%将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesRecent Insider Transactions Derivative • May 14Co-Founder exercised options to buy AU$689k worth of stock.On the 11th of May, Alexander Jannink exercised options to buy 511k shares at a strike price of around AU$0.55, costing a total of AU$282k. This transaction amounted to 3.3% of their direct individual holding at the time of the trade. Since June 2025, Alexander's direct individual holding has increased from 15.13m shares to 15.33m. This was the only transaction from an insider over the last 12 months.Reported Earnings • Mar 03First half 2026 earnings released: AU$0.15 loss per share (vs AU$0.004 loss in 1H 2025)First half 2026 results: AU$0.15 loss per share (further deteriorated from AU$0.004 loss in 1H 2025). Revenue: AU$40.3m (up 40% from 1H 2025). Net loss: AU$20.8m (loss widened AU$20.3m from 1H 2025). Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Software industry in Australia. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 170 percentage points per year, which is a significant difference in performance.Price Target Changed • Feb 27Price target increased by 12% to AU$2.40Up from AU$2.15, the current price target is an average from 2 analysts. New target price is 33% above last closing price of AU$1.80. Stock is up 49% over the past year. The company posted a net loss per share of AU$0.02 last year.New Risk • Feb 26New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 20% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 20% per year for the foreseeable future. Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (AU$5.4m net loss in 3 years). Shareholders have been diluted in the past year (16% increase in shares outstanding).分析記事 • Feb 15Acusensus Limited's (ASX:ACE) Business Is Yet to Catch Up With Its Share PriceWhen you see that almost half of the companies in the Software industry in Australia have price-to-sales ratios (or...お知らせ • Feb 11Acusensus Limited to Report First Half, 2026 Results on Feb 26, 2026Acusensus Limited announced that they will report first half, 2026 results on Feb 26, 2026New Risk • Dec 30New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 16% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 8.5% per year for the foreseeable future. Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (AU$3.5m net loss in 3 years). Shareholders have been diluted in the past year (16% increase in shares outstanding).お知らせ • Dec 16Acusensus Limited has completed a Follow-on Equity Offering in the amount of AUD 30 million.Acusensus Limited has completed a Follow-on Equity Offering in the amount of AUD 30 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 6,892,287 Price\Range: AUD 1.5 Discount Per Security: AUD 0.06 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 13,107,713 Price\Range: AUD 1.5 Discount Per Security: AUD 0.06 Transaction Features: Subsequent Direct ListingNew Risk • Nov 19New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 28% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 28% per year for the foreseeable future. Minor Risk Currently unprofitable and not forecast to become profitable over next 2 years (AU$4.6m net loss in 2 years).お知らせ • Oct 17Acusensus Limited, Annual General Meeting, Nov 19, 2025Acusensus Limited, Annual General Meeting, Nov 19, 2025. Location: dexus place, north tower, level 6, 80 collins street, melbourne vic 3000, AustraliaMajor Estimate Revision • Oct 09Consensus estimates of losses per share improve by 34%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has improved. 2026 revenue forecast increased from AU$81.3m to AU$83.9m. EPS estimate increased from -AU$0.031 per share to -AU$0.021 per share. Software industry in Australia expected to see average net income growth of 23% next year. Consensus price target up from AU$1.39 to AU$2.03. Share price rose 34% to AU$1.74 over the past week.New Risk • Oct 08New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 10% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 10% per year for the foreseeable future. Minor Risk Currently unprofitable and not forecast to become profitable over next 3 years (AU$3.7m net loss in 3 years).Price Target Changed • Oct 03Price target increased by 13% to AU$1.48Up from AU$1.31, the current price target is an average from 2 analysts. New target price is 9.3% above last closing price of AU$1.35. Stock is up 65% over the past year. The company is forecast to post a net loss per share of AU$0.024 next year compared to a net loss per share of AU$0.02 last year.分析記事 • Sep 23Little Excitement Around Acusensus Limited's (ASX:ACE) RevenuesYou may think that with a price-to-sales (or "P/S") ratio of 2.6x Acusensus Limited ( ASX:ACE ) is a stock worth...Reported Earnings • Aug 27Full year 2025 earnings released: AU$0.02 loss per share (vs AU$0.012 loss in FY 2024)Full year 2025 results: AU$0.02 loss per share (further deteriorated from AU$0.012 loss in FY 2024). Revenue: AU$59.4m (up 20% from FY 2024). Net loss: AU$2.62m (loss widened 72% from FY 2024). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Software industry in Australia.お知らせ • Aug 15Acusensus Limited to Report Fiscal Year 2025 Results on Aug 26, 2025Acusensus Limited announced that they will report fiscal year 2025 results on Aug 26, 2025New Risk • Mar 04New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 18% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 18% per year for the foreseeable future. Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (AU$3.8m net loss in 2 years). Significant insider selling over the past 3 months (AU$1.5m sold).New Risk • Mar 01New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: AU$160.9m (US$99.8m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (AU$471k net loss in 2 years). Significant insider selling over the past 3 months (AU$1.5m sold). Market cap is less than US$100m (AU$160.9m market cap, or US$99.8m).New Risk • Feb 28New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: AU$1.8m Forecast net loss in 2 years: AU$471k This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (AU$471k net loss in 2 years). Significant insider selling over the past 3 months (AU$1.5m sold).お知らせ • Feb 02Acusensus Limited to Report First Half, 2025 Results on Feb 27, 2025Acusensus Limited announced that they will report first half, 2025 results on Feb 27, 2025New Risk • Jan 11New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 11% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Shareholders have been diluted in the past year (11% increase in shares outstanding). Significant insider selling over the past 3 months (AU$1.5m sold). Market cap is less than US$100m (AU$149.0m market cap, or US$91.6m).分析記事 • Dec 20Investors Appear Satisfied With Acusensus Limited's (ASX:ACE) Prospects As Shares Rocket 25%Acusensus Limited ( ASX:ACE ) shares have continued their recent momentum with a 25% gain in the last month alone. The...お知らせ • Dec 20Acusensus Limited has completed a Follow-on Equity Offering in the amount of AUD 2.000001 million.Acusensus Limited has completed a Follow-on Equity Offering in the amount of AUD 2.000001 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 2,222,223 Price\Range: AUD 0.9 Discount Per Security: AUD 0.0405お知らせ • Dec 07Acusensus Limited has completed a Follow-on Equity Offering in the amount of AUD 10.000001 million.Acusensus Limited has completed a Follow-on Equity Offering in the amount of AUD 10.000001 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 11,111,112 Price\Range: AUD 0.9 Discount Per Security: AUD 0.0405 Transaction Features: Subsequent Direct Listingお知らせ • Dec 04+ 1 more updateAcusensus Limited has filed a Follow-on Equity Offering in the amount of AUD 2.000001 million.Acusensus Limited has filed a Follow-on Equity Offering in the amount of AUD 2.000001 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 2,222,223 Price\Range: AUD 0.9 Discount Per Security: AUD 0.0405お知らせ • Oct 17Acusensus Limited, Annual General Meeting, Nov 21, 2024Acusensus Limited, Annual General Meeting, Nov 21, 2024. Location: dexus place, north tower, level 6, 80 collins street, melbourne vic 3000, melbourne Australia分析記事 • Sep 04Improved Revenues Required Before Acusensus Limited (ASX:ACE) Stock's 30% Jump Looks JustifiedAcusensus Limited ( ASX:ACE ) shares have had a really impressive month, gaining 30% after a shaky period beforehand...New Risk • Sep 02New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 3 years. Trailing 12-month net loss: AU$1.5m Forecast net loss in 3 years: AU$1.2m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (AU$1.2m net loss in 3 years). Market cap is less than US$100m (AU$87.2m market cap, or US$59.0m).分析記事 • Aug 17Acusensus (ASX:ACE) Might Have The Makings Of A Multi-BaggerThere are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show two...Recent Insider Transactions • Jun 13Independent Non-Executive Director recently bought AU$75k worth of stockOn the 11th of June, Susan Klose bought around 125k shares on-market at roughly AU$0.60 per share. This transaction increased Susan's direct individual holding by 1x at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.分析記事 • Apr 24Acusensus (ASX:ACE) Is Looking To Continue Growing Its Returns On CapitalIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven...Price Target Changed • Feb 29Price target increased by 20% to AU$1.30Up from AU$1.08, the current price target is provided by 1 analyst. New target price is 59% above last closing price of AU$0.82. Stock is up 9.3% over the past year. The company posted earnings per share of AU$0.00049 last year.New Risk • Feb 27New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 23% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.2% net profit margin). Market cap is less than US$100m (AU$96.1m market cap, or US$62.9m).分析記事 • Jan 08There's Reason For Concern Over Acusensus Limited's (ASX:ACE) PriceWith a median price-to-sales (or "P/S") ratio of close to 2.4x in the Software industry in Australia, you could be...お知らせ • Oct 10Acusensus Limited Appoints Michael Lawrence Giuffrida as DirectorAcusensus Limited announced the appointment of Michael Lawrence Giuffrida as an independent non-executive Director, effective from October 9, 2023. Mr. Giuffrida's appointment follow the resignation of thomas patterson from the board in june 2023. Mr. Giuffrida is an entrepreneur with over 25 year of experience, having co=founded and been the CEO pf a human resource technology company, Acendre Pty Ltd. in 1997. Under Mike's leadership, acendre subsequently established a presence in the US, including in the US federal government market, before leading a process to identify a mojority growth investment partener for Acendre and subsequent acquisition of a US based HR technology company. At the end of 2019, Mike led a successfull trasition to a US based CEO to head up Acendre's next phase of growth, which enabled Mike to return to australia full time with his family.Reported Earnings • Aug 26Full year 2023 earnings releasedFull year 2023 results: Revenue: AU$42.0m (up 47% from FY 2022). Net income: AU$55.0k (down 96% from FY 2022). Profit margin: 0.1% (down from 5.0% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Software industry in Australia.New Risk • Aug 25New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Market cap is less than US$100m (AU$88.3m market cap, or US$56.6m).お知らせ • Aug 24Acusensus Limited, Annual General Meeting, Nov 16, 2023Acusensus Limited, Annual General Meeting, Nov 16, 2023.Buying Opportunity • Jul 12Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 7.2%. The fair value is estimated to be AU$4.12, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 70% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 37% in 2 years. Earnings is forecast to grow by 19% in the next 2 years.分析記事 • Jul 04Calculating The Intrinsic Value Of Acusensus Limited (ASX:ACE)Key Insights The projected fair value for Acusensus is AU$4.09 based on 2 Stage Free Cash Flow to Equity Acusensus...Reported Earnings • Feb 24First half 2023 earnings releasedFirst half 2023 results: AU$0.01 loss per share. Net loss: AU$262.8k (flat on 1H 2022).Valuation Update With 7 Day Price Move • Feb 23Investor sentiment improves as stock rises 21%After last week's 21% share price gain to AU$3.89, the stock trades at a trailing P/E ratio of 68.5x. Average trailing P/E is 53x in the Software industry in Australia.Board Change • Jan 12No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.決済の安定と成長配当データの取得安定した配当: ACEの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: ACEの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Acusensus 配当利回り対市場ACE 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (ACE)n/a市場下位25% (AU)2.8%市場トップ25% (AU)6.9%業界平均 (Software)1.3%アナリスト予想 (ACE) (最長3年)n/a注目すべき配当: ACEは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: ACEは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: ACEの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: ACEが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YAU 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/27 16:28終値2026/05/27 00:00収益2025/12/31年間収益2025/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Acusensus Limited 3 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。3 アナリスト機関Owen HumphriesCanaccord GenuityRoss BarrowsCanaccord Genuity Historic (Wilsons Advisory and Stockbroking Ltd.James FiliusMorgans Financial Limited
Recent Insider Transactions Derivative • May 14Co-Founder exercised options to buy AU$689k worth of stock.On the 11th of May, Alexander Jannink exercised options to buy 511k shares at a strike price of around AU$0.55, costing a total of AU$282k. This transaction amounted to 3.3% of their direct individual holding at the time of the trade. Since June 2025, Alexander's direct individual holding has increased from 15.13m shares to 15.33m. This was the only transaction from an insider over the last 12 months.
Reported Earnings • Mar 03First half 2026 earnings released: AU$0.15 loss per share (vs AU$0.004 loss in 1H 2025)First half 2026 results: AU$0.15 loss per share (further deteriorated from AU$0.004 loss in 1H 2025). Revenue: AU$40.3m (up 40% from 1H 2025). Net loss: AU$20.8m (loss widened AU$20.3m from 1H 2025). Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Software industry in Australia. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 170 percentage points per year, which is a significant difference in performance.
Price Target Changed • Feb 27Price target increased by 12% to AU$2.40Up from AU$2.15, the current price target is an average from 2 analysts. New target price is 33% above last closing price of AU$1.80. Stock is up 49% over the past year. The company posted a net loss per share of AU$0.02 last year.
New Risk • Feb 26New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 20% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 20% per year for the foreseeable future. Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (AU$5.4m net loss in 3 years). Shareholders have been diluted in the past year (16% increase in shares outstanding).
分析記事 • Feb 15Acusensus Limited's (ASX:ACE) Business Is Yet to Catch Up With Its Share PriceWhen you see that almost half of the companies in the Software industry in Australia have price-to-sales ratios (or...
お知らせ • Feb 11Acusensus Limited to Report First Half, 2026 Results on Feb 26, 2026Acusensus Limited announced that they will report first half, 2026 results on Feb 26, 2026
New Risk • Dec 30New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 16% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 8.5% per year for the foreseeable future. Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (AU$3.5m net loss in 3 years). Shareholders have been diluted in the past year (16% increase in shares outstanding).
お知らせ • Dec 16Acusensus Limited has completed a Follow-on Equity Offering in the amount of AUD 30 million.Acusensus Limited has completed a Follow-on Equity Offering in the amount of AUD 30 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 6,892,287 Price\Range: AUD 1.5 Discount Per Security: AUD 0.06 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 13,107,713 Price\Range: AUD 1.5 Discount Per Security: AUD 0.06 Transaction Features: Subsequent Direct Listing
New Risk • Nov 19New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 28% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 28% per year for the foreseeable future. Minor Risk Currently unprofitable and not forecast to become profitable over next 2 years (AU$4.6m net loss in 2 years).
お知らせ • Oct 17Acusensus Limited, Annual General Meeting, Nov 19, 2025Acusensus Limited, Annual General Meeting, Nov 19, 2025. Location: dexus place, north tower, level 6, 80 collins street, melbourne vic 3000, Australia
Major Estimate Revision • Oct 09Consensus estimates of losses per share improve by 34%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has improved. 2026 revenue forecast increased from AU$81.3m to AU$83.9m. EPS estimate increased from -AU$0.031 per share to -AU$0.021 per share. Software industry in Australia expected to see average net income growth of 23% next year. Consensus price target up from AU$1.39 to AU$2.03. Share price rose 34% to AU$1.74 over the past week.
New Risk • Oct 08New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 10% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 10% per year for the foreseeable future. Minor Risk Currently unprofitable and not forecast to become profitable over next 3 years (AU$3.7m net loss in 3 years).
Price Target Changed • Oct 03Price target increased by 13% to AU$1.48Up from AU$1.31, the current price target is an average from 2 analysts. New target price is 9.3% above last closing price of AU$1.35. Stock is up 65% over the past year. The company is forecast to post a net loss per share of AU$0.024 next year compared to a net loss per share of AU$0.02 last year.
分析記事 • Sep 23Little Excitement Around Acusensus Limited's (ASX:ACE) RevenuesYou may think that with a price-to-sales (or "P/S") ratio of 2.6x Acusensus Limited ( ASX:ACE ) is a stock worth...
Reported Earnings • Aug 27Full year 2025 earnings released: AU$0.02 loss per share (vs AU$0.012 loss in FY 2024)Full year 2025 results: AU$0.02 loss per share (further deteriorated from AU$0.012 loss in FY 2024). Revenue: AU$59.4m (up 20% from FY 2024). Net loss: AU$2.62m (loss widened 72% from FY 2024). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Software industry in Australia.
お知らせ • Aug 15Acusensus Limited to Report Fiscal Year 2025 Results on Aug 26, 2025Acusensus Limited announced that they will report fiscal year 2025 results on Aug 26, 2025
New Risk • Mar 04New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 18% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 18% per year for the foreseeable future. Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (AU$3.8m net loss in 2 years). Significant insider selling over the past 3 months (AU$1.5m sold).
New Risk • Mar 01New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: AU$160.9m (US$99.8m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (AU$471k net loss in 2 years). Significant insider selling over the past 3 months (AU$1.5m sold). Market cap is less than US$100m (AU$160.9m market cap, or US$99.8m).
New Risk • Feb 28New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: AU$1.8m Forecast net loss in 2 years: AU$471k This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (AU$471k net loss in 2 years). Significant insider selling over the past 3 months (AU$1.5m sold).
お知らせ • Feb 02Acusensus Limited to Report First Half, 2025 Results on Feb 27, 2025Acusensus Limited announced that they will report first half, 2025 results on Feb 27, 2025
New Risk • Jan 11New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 11% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Shareholders have been diluted in the past year (11% increase in shares outstanding). Significant insider selling over the past 3 months (AU$1.5m sold). Market cap is less than US$100m (AU$149.0m market cap, or US$91.6m).
分析記事 • Dec 20Investors Appear Satisfied With Acusensus Limited's (ASX:ACE) Prospects As Shares Rocket 25%Acusensus Limited ( ASX:ACE ) shares have continued their recent momentum with a 25% gain in the last month alone. The...
お知らせ • Dec 20Acusensus Limited has completed a Follow-on Equity Offering in the amount of AUD 2.000001 million.Acusensus Limited has completed a Follow-on Equity Offering in the amount of AUD 2.000001 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 2,222,223 Price\Range: AUD 0.9 Discount Per Security: AUD 0.0405
お知らせ • Dec 07Acusensus Limited has completed a Follow-on Equity Offering in the amount of AUD 10.000001 million.Acusensus Limited has completed a Follow-on Equity Offering in the amount of AUD 10.000001 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 11,111,112 Price\Range: AUD 0.9 Discount Per Security: AUD 0.0405 Transaction Features: Subsequent Direct Listing
お知らせ • Dec 04+ 1 more updateAcusensus Limited has filed a Follow-on Equity Offering in the amount of AUD 2.000001 million.Acusensus Limited has filed a Follow-on Equity Offering in the amount of AUD 2.000001 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 2,222,223 Price\Range: AUD 0.9 Discount Per Security: AUD 0.0405
お知らせ • Oct 17Acusensus Limited, Annual General Meeting, Nov 21, 2024Acusensus Limited, Annual General Meeting, Nov 21, 2024. Location: dexus place, north tower, level 6, 80 collins street, melbourne vic 3000, melbourne Australia
分析記事 • Sep 04Improved Revenues Required Before Acusensus Limited (ASX:ACE) Stock's 30% Jump Looks JustifiedAcusensus Limited ( ASX:ACE ) shares have had a really impressive month, gaining 30% after a shaky period beforehand...
New Risk • Sep 02New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 3 years. Trailing 12-month net loss: AU$1.5m Forecast net loss in 3 years: AU$1.2m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (AU$1.2m net loss in 3 years). Market cap is less than US$100m (AU$87.2m market cap, or US$59.0m).
分析記事 • Aug 17Acusensus (ASX:ACE) Might Have The Makings Of A Multi-BaggerThere are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show two...
Recent Insider Transactions • Jun 13Independent Non-Executive Director recently bought AU$75k worth of stockOn the 11th of June, Susan Klose bought around 125k shares on-market at roughly AU$0.60 per share. This transaction increased Susan's direct individual holding by 1x at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.
分析記事 • Apr 24Acusensus (ASX:ACE) Is Looking To Continue Growing Its Returns On CapitalIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven...
Price Target Changed • Feb 29Price target increased by 20% to AU$1.30Up from AU$1.08, the current price target is provided by 1 analyst. New target price is 59% above last closing price of AU$0.82. Stock is up 9.3% over the past year. The company posted earnings per share of AU$0.00049 last year.
New Risk • Feb 27New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 23% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.2% net profit margin). Market cap is less than US$100m (AU$96.1m market cap, or US$62.9m).
分析記事 • Jan 08There's Reason For Concern Over Acusensus Limited's (ASX:ACE) PriceWith a median price-to-sales (or "P/S") ratio of close to 2.4x in the Software industry in Australia, you could be...
お知らせ • Oct 10Acusensus Limited Appoints Michael Lawrence Giuffrida as DirectorAcusensus Limited announced the appointment of Michael Lawrence Giuffrida as an independent non-executive Director, effective from October 9, 2023. Mr. Giuffrida's appointment follow the resignation of thomas patterson from the board in june 2023. Mr. Giuffrida is an entrepreneur with over 25 year of experience, having co=founded and been the CEO pf a human resource technology company, Acendre Pty Ltd. in 1997. Under Mike's leadership, acendre subsequently established a presence in the US, including in the US federal government market, before leading a process to identify a mojority growth investment partener for Acendre and subsequent acquisition of a US based HR technology company. At the end of 2019, Mike led a successfull trasition to a US based CEO to head up Acendre's next phase of growth, which enabled Mike to return to australia full time with his family.
Reported Earnings • Aug 26Full year 2023 earnings releasedFull year 2023 results: Revenue: AU$42.0m (up 47% from FY 2022). Net income: AU$55.0k (down 96% from FY 2022). Profit margin: 0.1% (down from 5.0% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Software industry in Australia.
New Risk • Aug 25New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Market cap is less than US$100m (AU$88.3m market cap, or US$56.6m).
お知らせ • Aug 24Acusensus Limited, Annual General Meeting, Nov 16, 2023Acusensus Limited, Annual General Meeting, Nov 16, 2023.
Buying Opportunity • Jul 12Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 7.2%. The fair value is estimated to be AU$4.12, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 70% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 37% in 2 years. Earnings is forecast to grow by 19% in the next 2 years.
分析記事 • Jul 04Calculating The Intrinsic Value Of Acusensus Limited (ASX:ACE)Key Insights The projected fair value for Acusensus is AU$4.09 based on 2 Stage Free Cash Flow to Equity Acusensus...
Reported Earnings • Feb 24First half 2023 earnings releasedFirst half 2023 results: AU$0.01 loss per share. Net loss: AU$262.8k (flat on 1H 2022).
Valuation Update With 7 Day Price Move • Feb 23Investor sentiment improves as stock rises 21%After last week's 21% share price gain to AU$3.89, the stock trades at a trailing P/E ratio of 68.5x. Average trailing P/E is 53x in the Software industry in Australia.
Board Change • Jan 12No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.